Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
155
NCT01829971
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
Phase: Phase 1
Role: Lead Sponsor
Start: Apr 30, 2013
Completion: May 31, 2017
NCT02862145
Pharmacodynamics Study of MRX34, MicroRNA Liposomal Injection in Melanoma Patients With Biopsy Accessible Lesions
Phase: Phase 1/2
Start: Aug 31, 2016
Completion: Dec 31, 2017